CEREBRAL AMYLOID ANGIOPATHY
Clinical trials for CEREBRAL AMYLOID ANGIOPATHY explained in plain language.
Never miss a new study
Get alerted when new CEREBRAL AMYLOID ANGIOPATHY trials appear
Sign up with your email to follow new studies for CEREBRAL AMYLOID ANGIOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental brain injection aims to slow dangerous blood vessel disease
Disease control Recruiting nowThis study is testing whether a medication called ALN-APP, given as an injection into the spinal fluid, can slow down the progression of cerebral amyloid angiopathy (CAA). CAA is a disease where a sticky protein builds up in the brain's blood vessels, making them fragile and pron…
Matched conditions: CEREBRAL AMYLOID ANGIOPATHY
Phase: PHASE2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Could a simple eye scan spot a dangerous brain condition?
Diagnosis Recruiting nowThis study is testing a new dye called AMDX-2011P to see if it can safely help doctors spot signs of cerebral amyloid angiopathy (CAA) in the back of the eye. Researchers will give a single dose of the dye to 25 participants with CAA and then take pictures of their retinas. The m…
Matched conditions: CEREBRAL AMYLOID ANGIOPATHY
Phase: PHASE2 • Sponsor: Amydis Inc. • Aim: Diagnosis
Last updated Mar 27, 2026 12:38 UTC